Showing results (401-410 of 5,984) with videos related to

Sort By:
Pageof 599
Molecular Cancer Therapeutics|December 14, 2002
Interaction of the novel anthracycline antitumor agent N-benzyladriamycin-14-valerate with the C1-regulatory domain of protein kinase C: structural requirements, isoform specificity, and correlation with drug cytotoxicityJ Brent Roaten, Marcelo G Kazanietz, Maria Jose Caloca, et al.
Molecular Cancer Therapeutics|December 14, 2002
Molecular advances in pretargeting radioimunotherapy with bispecific antibodiesChien-Hsing Chang, Robert M Sharkey, Edmund A Rossi, et al.
Molecular Cancer Therapeutics|December 14, 2002
p53 mediates DNA damaging drug-induced apoptosis through a caspase-9-dependent pathway in SH-SY5Y neuroblastoma cellsHongjuan Cui, Allen Schroering, Han-Fei Ding
Molecular Cancer Therapeutics|December 14, 2002
Constitutive and inducible Akt activity promotes resistance to chemotherapy, trastuzumab, or tamoxifen in breast cancer cellsAmy S Clark, Kip West, Samantha Streicher, et al.
Molecular Cancer Therapeutics|December 14, 2002
Mechanisms of resistance to 1,3-bis(2-chloroethyl)-1-nitrosourea in human medulloblastoma and rhabdomyosarcomaManny D Bacolod, Stewart P Johnson, Francis Ali-Osman, et al.
Molecular Cancer Therapeutics|December 14, 2002
Targeting the tumor microenvironment with chemically modified tetracyclines: inhibition of laminin 5 gamma2 chain promigratory fragments and vasculogenic mimicryRichard E B Seftor, Elisabeth A Seftor, Dawn A Kirschmann, et al.
Molecular Cancer Therapeutics|December 14, 2002
Cell cycle blockade and differentiation of ovarian cancer cells by the histone deacetylase inhibitor trichostatin A are associated with changes in p21, Rb, and Id proteinsKevin A Strait, Bashar Dabbas, Elizabeth H Hammond, et al.
Molecular Cancer Therapeutics|December 14, 2002
The anthelmintic drug mebendazole induces mitotic arrest and apoptosis by depolymerizing tubulin in non-small cell lung cancer cellsJi-ichiro Sasaki, Rajagopal Ramesh, Sunil Chada, et al.
Molecular Cancer Therapeutics|December 14, 2002
Molecular modeling of mutations in the DNA-binding domain of the oncoprotein QinSharmila Banerjee-Basu, Andreas D Baxevanis
Molecular Cancer Therapeutics|December 13, 2002
Conditionally replicative adenoviruses for ovarian cancer therapyMack N Barnes, Candace J Coolidge, Akseli Hemminki, et al.
Pageof 599